172 related articles for article (PubMed ID: 381722)
1. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
Inai S
Nihon Rinsho; 1979 May; 37(5):923-9. PubMed ID: 381722
[No Abstract] [Full Text] [Related]
2. [Progress in the knowledge of complement. II. Nephritic factors].
Leibowitch J; Lesavre P
Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
[No Abstract] [Full Text] [Related]
3. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
Ito S; Tamura N; Fujita T
Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
[TBL] [Abstract][Full Text] [Related]
4. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
Lesavre P; Leibowitch J
Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
[No Abstract] [Full Text] [Related]
5. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
Fearon DT; Austen KF
N Engl J Med; 1980 Jul; 303(5):259-63. PubMed ID: 6900901
[No Abstract] [Full Text] [Related]
6. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
7. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
8. [Complement: mechanisms of activation, functions, analysis].
Dessaint JP; Wattre P; Santoro F; Capron A
Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
[No Abstract] [Full Text] [Related]
9. The quest for an intrinsic C3 activating factor in human glomerular disease.
Roberts JL; Lewis EJ
Surv Immunol Res; 1982; 1(2):191-8. PubMed ID: 6227068
[No Abstract] [Full Text] [Related]
10. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
11. [Protein chemistry of the complement system].
Nagasawa S
Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
[No Abstract] [Full Text] [Related]
12. The role of complement in glomerulonephritis.
Simpson IJ
Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
[No Abstract] [Full Text] [Related]
13. The human alternative complement pathway: biology and immunopathology of activation and regulation.
Kazatchkine MD; Nydegger UE
Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
[No Abstract] [Full Text] [Related]
14. [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].
Nakanishi I
Nihon Jinzo Gakkai Shi; 1981 Jun; 23(6):719-32. PubMed ID: 6914399
[No Abstract] [Full Text] [Related]
15. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
16. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
17. [Complement and bio-phylaxis].
Nihon Rinsho; 1990 Jul; 48 Suppl():342-440. PubMed ID: 2214200
[No Abstract] [Full Text] [Related]
18. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Daha MR; Van Es LA
Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
[No Abstract] [Full Text] [Related]
19. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
20. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
McLean RH; Nilson SH
Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
